Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:07:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer's revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:01:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a basic error screen. A Home link and standard footer appear, indicating the page is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-20T20:47:50.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Added 2016 ( U.S. NIH Grant/Contract ) and Revision: v3.6.6, while Revision: v3.6.5 was removed. These updates reflect funding disclosures and versioning metadata rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-30T22:22:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - The page revision updated from v3.6.4 to v3.6.5, signaling a new software release of the page. - The update likely includes minor fixes or improvements but does not alter the study content or visible user-facing features.
    Difference
    0.1%
    Check dated 2026-08-09T11:21:44.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.3 to v3.6.4, signaling a minor update to the ClinicalTrials.gov entry. This change does not modify the study details, eligibility criteria, or other substantive content.
    Difference
    0.1%
    Check dated 2026-07-26T00:14:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.